No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs538251647 |
chr11:3982328-3982329 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs187515094 |
chr11:3982337-3982338 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs78975511 |
chr11:3982356-3982357 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs565623652 |
chr11:3982362-3982363 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs142296787 |
chr11:3982370-3982371 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs192326087 |
chr11:3982377-3982378 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs554708920 |
chr11:3982378-3982379 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs576265767 |
chr11:3982389-3982390 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs543684460 |
chr11:3982390-3982391 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs558573557 |
chr11:3982392-3982393 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs61188198 |
chr11:3982408-3982409 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs397972736 |
chr11:3982412-3982413 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs577099233 |
chr11:3982436-3982437 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs545061599 |
chr11:3982532-3982533 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs12223176 |
chr11:3982537-3982538 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
16 |
rs574194762 |
chr11:3982597-3982598 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs542662263 |
chr11:3982615-3982616 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs373937856 |
chr11:3982617-3982618 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs116715480 |
chr11:3982629-3982630 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs184831664 |
chr11:3982669-3982670 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs565416885 |
chr11:3982724-3982725 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs377127220 |
chr11:3982727-3982728 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs576284240 |
chr11:3982739-3982740 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs28586875 |
chr11:3982741-3982742 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs28380349 |
chr11:3982743-3982744 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs200357765 |
chr11:3982744-3982745 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs7925954 |
chr11:3982746-3982747 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
28 |
rs368402572 |
chr11:3982747-3982748 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs547790868 |
chr11:3982748-3982749 |
Weak transcription Enhancers
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs565624813 |
chr11:3982787-3982788 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs7938862 |
chr11:3982792-3982793 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs544016217 |
chr11:3982796-3982797 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs569815271 |
chr11:3982808-3982809 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs112842567 |
chr11:3982809-3982810 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs563871768 |
chr11:3982826-3982827 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs368368268 |
chr11:3982831-3982832 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs148269497 |
chr11:3982841-3982842 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs12283447 |
chr11:3982842-3982843 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
39 |
rs534887203 |
chr11:3982849-3982850 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs113155104 |
chr11:3982858-3982859 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs113418571 |
chr11:3982861-3982862 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs192607355 |
chr11:3982922-3982923 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs113618957 |
chr11:3982931-3982932 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs542651665 |
chr11:3982938-3982939 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs543764745 |
chr11:3982946-3982947 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|